15 Results for "

B-CDK1

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "B-CDK1" in MCE Product Catalog:

84
84 Publications Verification
Cat. No.: HY-15777
CAS No.: 1211441-98-3
Purity:  99.94%
Synonyms: LEE011
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1] .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777A
CAS No.: 1211443-80-9
Purity:  99.93%
Synonyms: LEE011 hydrochloride
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) hydrochloride is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1] .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777B
CAS No.: 1374639-75-4
Purity:  99.93%
Synonyms: LEE011 succinate
Target:  

CDK

Research Areas:  

Neurological Disease Cancer

RRibociclib (LEE011) succinate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1] .
loading...
    loading...
84
84 Publications Verification
Cat. No.: HY-15777C
CAS No.: 1374639-79-8
Purity:  99.94%
Synonyms: LEE011 succinate hydrate
Target:  

CDK

Research Areas:  

Cancer

RRibociclib (LEE011) succinate hydrate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1] .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10424
CAS No.: 802539-81-7
Purity:  99.90%
Synonyms: PHA-848125
Target:  

CDK Autophagy

Research Areas:  

Cancer

Milciclib (PHA-848125) is a potent, ATP-competitive and dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively.
loading...
    loading...
Cat. No.: HY-15777S
CAS No.: 1328934-40-2
Synonyms: LEE011-d6
Ribociclib-d6 (LEE011-d6) is a deuterium labeled Ribociclib (HY-15777). Ribociclib is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1].
loading...
    loading...
Cat. No.: HY-103382
CAS No.: 118458-54-1
Purity:  99.8%
Arcyriaflavin A is an indolo[2,3-a]carbazole compound and also a cyclin D1/CDK4 inhibitor. Arcyriaflavin A exists in the marine ascidian Eudistoma sp. and the slime mold Arcyria denudata. Arcyriaflavin A is applicable to research related to colon cancer and lung cancer [1] .
loading...
    loading...
Cat. No.: HY-15777R
CAS No.: 1211441-98-3
Synonyms: LEE011 (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Ribociclib (Standard) is the analytical standard of Ribociclib. This product is intended for research and analytical applications. Ribociclib (LEE01) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1].
loading...
    loading...
Cat. No.: HY-15777AS
CAS No.: 2934109-69-8
Purity:  98.26%
Synonyms: LEE011-d6 hydrochloride
Ribociclib-d6 (LEE011-d6) hydrochloride is a deuterium labeled Ribociclib. Ribociclib is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex [1].
loading...
    loading...
Cat. No.: HY-15777S1
CAS No.: 2167898-24-8
Purity:  99.23%
Synonyms: LEE011-d8
Ribociclib-d8 is the deuterium labeled Ribociclib [1]. Ribociclib (LEE01) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
Cat. No.: HY-15777AR
CAS No.: 1211443-80-9
Synonyms: LEE011 hydrochloride (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Ribociclib (Standard) (LEE011(Standard)) hydrochloride is the analytical standard of Ribociclib hydrochloride (HY-15777A). This product is intended for research and analytical applications. Ribociclib hydrochloride (LEE011 hydrochloride) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.
loading...
    loading...
Cat. No.: HY-15777BR
CAS No.: 1374639-75-4
Synonyms: LEE011 succinate (Standard)
Target:  

CDK Reference Standards

Research Areas:  

Cancer

Ribociclib succinate (Standard) is the analytical standard of Ribociclib succinate. This product is intended for research and analytical applications. Ribociclib succinate (LEE011 succinate) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.
loading...
    loading...
Cat. No.: HY-10424R
CAS No.: 802539-81-7
Synonyms: PHA-848125 (Standard)
Research Areas:  

Cancer

Milciclib (Standard) is the analytical standard of Milciclib. This product is intended for research and analytical applications. Milciclib (PHA-848125) is a potent, ATP-competitive and dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively.
loading...
    loading...
Cat. No.: HY-183118
CAS No.: 3064485-16-8
Target:  

CDK Apoptosis

Research Areas:  

Neurological Disease Cancer

CID-078 is an orally active macrocyclic cyclin A and cyclin B inhibitor. CID-078 binds cyclin hydrophobic patches, disrupting interactions of cyclin A-Cdk2 with E2F1 and cyclin B-Cdk1 with Myt1, and selectively targets RxL binding motifs to block complex-substrate interactions. CID-078 induces DNA damage, G2/M cell cycle arrest, apoptosis, mitotic catastrophe, spindle assembly checkpoint activation, and neomorphic cyclin B-CDK2 complex formation, driving synthetic lethality in E2F-driven cancer cells. CID-078 can be used for the research of small cell lung cancer, non-small cell lung cancer, triple negative breast cancer, advanced solid tumors, luminal HR +/HER 2- breast cancer, RB1-altered solid tumors, and neuroblastoma [1] .
loading...
    loading...
Cat. No.: HY-114214
CAS No.: 626252-75-3
CKD-712 is an orally active multi-target tetrahydroisoquinoline derivatived and a potent inhibitor of the NF-κB pathway . CKD-712 selectively inhibits MMP-9 with no effect on MMP-2, downregulates the expression of TNF-α, IL-6, cyclin A, cyclin B, CDK-1 and other proteins, and activates the PI3K/Akt signaling pathway [1] . CKD-712 blocks the activation and nuclear translocation of NF-κB, downregulates inflammatory factors and pro-tumor metastatic proteins, and induces G2/M phase arrest in tumor cells and thereby inhibits the invasion of cancer cells [1] . CKD-712 can be used for the research of sepsis, myocardial ischemia-reperfusion injury and non-small cell lung cancer [1] .
loading...
    loading...
  • 1